Literature DB >> 17554617

Genetic analysis of RET, EDNRB, and EDN3 genes and three SNPs in MCS + 9.7 in Chinese Patients with isolated Hirschsprung disease.

Xian-Ning Zhang1, Miao-Ni Zhou, Yun-Qing Qiu, Shi-Ping Ding, Ming Qi, Ji-Cheng Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554617     DOI: 10.1007/s10528-007-9093-y

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


× No keyword cloud information.
  6 in total

1.  RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population.

Authors:  Cuiping Liu; Lei Jin; Hui Li; Jintu Lou; Chunfen Luo; Xuewu Zhou; Ji-Cheng Li
Journal:  J Hum Genet       Date:  2008-07-08       Impact factor: 3.172

2.  RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis.

Authors:  C Tomuschat; P Puri
Journal:  Pediatr Surg Int       Date:  2015-07-12       Impact factor: 1.827

3.  Novel mutations of endothelin-B receptor gene in Pakistani patients with Waardenburg syndrome.

Authors:  Raheela Jabeen; Masroor Ellahi Babar; Jamil Ahmad; Ali Raza Awan
Journal:  Mol Biol Rep       Date:  2011-05-06       Impact factor: 2.316

Review 4.  Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives.

Authors:  Consolato Maria Sergi; Oana Caluseriu; Hunter McColl; David D Eisenstat
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

5.  ASSOCIATION OF RS2435357 AND RS1800858 POLYMORPHISMS IN RET PROTO-ONCOGENE WITH HIRSCHSPRUNG DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS.

Authors:  Abdolhamid Amooee; Mohamad Hosein Lookzadeh; Seyed Reza Mirjalili; Seyed Mohsen Miresmaeili; Kazem Aghili; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  Arq Bras Cir Dig       Date:  2019-10-21

6.  RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis.

Authors:  Chun-mei Liang; Dong-mei Ji; Xu Yuan; Ling-ling Ren; Juan Shen; Hai-yan Zhang
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.